Fourth | Jotup

MagicSnow Celebrates 20 Years of Snowmaking

Retrieved on:

木曜日, 11月 2, 2023

Sport, Universal Pictures, Cosmopolitan of Las Vegas, System, Temperature, MagicSnow, Multimedia, Magic, Antara Polanco, Snow, Amusement park, Princess Cruises, Fourth, NBC Sports, Rockefeller Center, Cosmopolitan, Radio City, Entertainment, Resort

HOLLYWOOD, Calif., Nov. 2, 2023 /PRNewswire/ -- MagicSnow, a pioneer in the world of innovative snow effects and experiences, celebrates its 20th anniversary this holiday season.

Key Points:

HOLLYWOOD, Calif., Nov. 2, 2023 /PRNewswire/ -- MagicSnow, a pioneer in the world of innovative snow effects and experiences, celebrates its 20th anniversary this holiday season.
For more than two decades, MagicSnow has redefined the possibilities of snow special effects, captivating audiences and creating new traditions with its immersive snow experiences.
MagicSnow was founded in 2002 by Adam Williams, who envisioned bringing snow to any location in the world, no matter the temperature or location.
MagicSnow envisions a future where it can redefine what's possible in snow effects, promising to deliver unforgettable experiences for the next 20 years and beyond.

Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023

Retrieved on:

火曜日, 10月 24, 2023

FDA, Food, Security, Note, Regulation of tobacco by the U.S. Food and Drug Administration, Citric acid, OTCQB, Lactic acid, Lactic acid/citric acid/potassium bitartrate, Growth, Marketing, File, New Drug Application, Fourth, Abbreviated New Drug Application, Fourth Amendment, Constitutional right, Video game, Pharmaceutical industry

SAN DIEGO, Oct. 24, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFMD) ("Evofem") today announced preliminary results for the third quarter of 2023, including sequential growth in net product sales of its hormone-free prescription contraceptive gel, Phexxi® (lactic acid, citric acid and potassium bitartrate) and the positive impact of ongoing cost containment initiatives.

Key Points:

Phexxi net product sales expected to be $5.0 to $5.2 million for the third quarter of 2023.
Selling and marketing expenses were more than 75% lower and total operating expenses were more than 65% lower in the third quarter of 2023 than the third quarter of 2022.
Reduced loss from operations by more than 80% in the third quarter of 2023 as compared to the third quarter of 2022.
The Company expects to report full unaudited results for the three- and nine- months ended September 30, 2023, in mid-November.

The Fourth World Lemon Industry Development Conference was held in Anyue, China

Retrieved on:

水曜日, 10月 18, 2023

Investment, United Arab Emirates, Budweiser, Conference, Citric acid, Multilateralism, Growth, Marketing, Antioxidant, VC, Fourth, Nutrient, Tea

ANYUE, China, Oct. 18, 2023 /PRNewswire/ -- On October 18, the Fourth World Lemon Industry Development Conference, organized by Anyue County People's Government, was held in Anyue County, Sichuan Province.

Key Points:

ANYUE, China, Oct. 18, 2023 /PRNewswire/ -- On October 18, the Fourth World Lemon Industry Development Conference, organized by Anyue County People's Government, was held in Anyue County, Sichuan Province.
At the event, seven projects, including the Budweiser Beer Anyue Lime Base Project and the Russia's 20,000-ton Lemon Procurement Project were contracted.
On the day of the event, the Lemon Industry Chain International (Technology) Cooperation and Exchange Conference and the Lemon Branding Sharing Conference & Investment Promotion Conference were successively held, providing participants with a professional platform for face-to-face experience exchange, international cooperation, and economic and trade negotiations.
Anyue County, located in Ziyang City, Sichuan Province, China, is one of the five major lemon producing areas in the world and the only commercial lemon production base in China, known as the "Hometown of Chinese Lemons".

The Fourth World Lemon Industry Development Conference was held in Anyue, China

Retrieved on:

水曜日, 10月 18, 2023

Investment, United Arab Emirates, Budweiser, Conference, Citric acid, Multilateralism, Growth, Marketing, Antioxidant, VC, Fourth, Nutrient, Tea

ANYUE, China, Oct. 18, 2023 /PRNewswire/ -- On October 18, the Fourth World Lemon Industry Development Conference, organized by Anyue County People's Government, was held in Anyue County, Sichuan Province.

Key Points:

ANYUE, China, Oct. 18, 2023 /PRNewswire/ -- On October 18, the Fourth World Lemon Industry Development Conference, organized by Anyue County People's Government, was held in Anyue County, Sichuan Province.
At the event, seven projects, including the Budweiser Beer Anyue Lime Base Project and the Russia's 20,000-ton Lemon Procurement Project were contracted.
On the day of the event, the Lemon Industry Chain International (Technology) Cooperation and Exchange Conference and the Lemon Branding Sharing Conference & Investment Promotion Conference were successively held, providing participants with a professional platform for face-to-face experience exchange, international cooperation, and economic and trade negotiations.
Anyue County, located in Ziyang City, Sichuan Province, China, is one of the five major lemon producing areas in the world and the only commercial lemon production base in China, known as the "Hometown of Chinese Lemons".

Samsung Bioepis Releases Fourth Quarter 2023 US Biosimilar Market Report to Provide the Latest US Market Biosimilar Trends

Retrieved on:

火曜日, 10月 10, 2023

CMS, Fourth, ASP, Centers for Medicare & Medicaid Services, Market access, Generic drug

INCHEON, South Korea, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today released the Fourth Quarter 2023 Biosimilar Market Report which explores latest market trends for all biosimilars commercially available in the United States.

Key Points:

INCHEON, South Korea, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today released the Fourth Quarter 2023 Biosimilar Market Report which explores latest market trends for all biosimilars commercially available in the United States.
The report also explores three key determinants influencing the degree of biosimilar utilization:
“We are pleased to successfully present our third biosimilar market report to US stakeholders.
Samsung Bioepis will always strive to deliver richer and timely content to our readers,” he added.
Samsung Bioepis Biosimilar Market Report, which was first published in April 2023, is being published every quarter after the CMS publishes updated ASP values for each product.

Joint Statement from the Co-Chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses - Latest National Data on Substance-Related Harms

Retrieved on:

木曜日, 9月 28, 2023

This release provides an update on data collected from January to March 2023 and builds on historical data that has been collected every quarter since 2016.

Key Points:

This release provides an update on data collected from January to March 2023 and builds on historical data that has been collected every quarter since 2016.
These latest data suggest that in Canada between January and March 2023, there were 1,904 opioid-related deaths – or an average of 21 deaths per day.
This represents a similar mortality rate to what has been observed since the start of the COVID-19 pandemic, when the number of opioid-related deaths increased.
The report highlights that repeat interactions with the healthcare system could provide opportunities to support individuals experiencing substance-related harms.

FAVOR DELIVERY SHARES INAUGURAL DATA REPORT REVEALING HOW TEXAS ORDERS IN

Retrieved on:

水曜日, 9月 20, 2023

Taste, BBQ, University, Snack, WINE, Life, Student, BIG, DOG, Rice University, Culture, COFFEE, University of Texas at Austin, SUSHI, DR, Flour, Austinite, HOT, PASTA, Fourth, Texas Christian University, CHICKEN, Baylor University, Protein, Holiday, New Year's Eve, Dog, OTC, DOGS, City, TEA, EGG, SALSA, Condiment, TACOS, Fast food

AUSTIN, Texas, Sept. 20, 2023 /PRNewswire/ -- Favor Delivery, the only restaurant delivery app by and for Texans that is part of H-E-B, released today its first-ever How Texas Orders In Report. Launched in conjunction with the company's latest brand campaign by the same name, the report provides an inside look into the palates and preferences of Texas residents across the state over the past year.

Key Points:

AUSTIN, Texas, Sept. 20, 2023 /PRNewswire/ -- Favor Delivery , the only restaurant delivery app by and for Texans that is part of H-E-B, released today its first-ever How Texas Orders In Report .
"As Texas' only Texas-based food delivery app serving over 400 cities, we have an incredible number of insights on how Texas orders in," said Keith Duncan, Favor Delivery CEO.
The report also highlights non-food items that are essential to life in Texas, such as sunscreen and allergy medicine, and other iconically Texan items, like cowboy boots.
Favor – it's more than just food delivery:
Dallas-Fort Worth demonstrates Texas pride with the most COWBOY BOOTS and HATS ordered.

CREDEVOLV IS MAKING CHANGE IN AN INDUSTRY PLAGUED WITH PROBLEMS

Retrieved on:

水曜日, 9月 13, 2023

Fourth, Entrepreneurship, Housing, University of California, Berkeley, Fraud, UC, Management, Credit

NAPLES, Fla., Sept. 13, 2023 /PRNewswire/ -- In an industry plagued by fraud and deceptive practices, CredEvolv continues to be a beacon of change within the credit repair space. On August 16, CredEvolv was named as one of five ventures accepted into the Fourth Annual Housing Lab cohort.

Key Points:

NAPLES, Fla., Sept. 13, 2023 /PRNewswire/ -- In an industry plagued by fraud and deceptive practices, CredEvolv continues to be a beacon of change within the credit repair space.
On August 16, CredEvolv was named as one of five ventures accepted into the Fourth Annual Housing Lab cohort.
This distinction will provide CredEvolv with a grant, along with strategic coaching and technical assistance to help further its mission.
"When we started this company, we had a vision to make change in an industry that, frankly, has needed it for so long.

SAS doubles down on partner strategy to supercharge future growth

Retrieved on:

火曜日, 9月 12, 2023

LAS VEGAS, Sept. 12, 2023 /PRNewswire/ -- SAS EXPLORE -- SAS, the leader in AI and analytics, is elevating partners in its company strategy to drive growth, enable innovation and empower customers. SAS has taken its partner program to the next level with game-changing updates that spell out success for customers and partners alike.

Key Points:

SAS has taken its partner program to the next level with game-changing updates that spell out success for customers and partners alike.
SAS Health is a new cloud-native industry offering that includes SAS partner SingleStore.
Intel is also instrumental in supporting key initiatives and events, including the annual SAS Hackathon, SAS Innovate on Tour and SAS Explore.
SAS presented Linktera, a leading SAS solution provider in the Middle East, with its Distinguished Partner Award.

Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor

Retrieved on:

月曜日, 9月 11, 2023

Exercise, Security, Fourth Amendment, Fourth, Note, OTCQB, Constitutional right, SAN, Security (finance)

SAN DIEGO, Sept. 11, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the "Company") today announced it has successfully negotiated and entered into a fourth amendment (the "Fourth Amendment") to its Securities Purchase and Security Agreement dated April 2020, as amended (the "2020 S.P.A."), with a U.S.-based, healthcare-focused institutional investor (the "Investor"), under which the Investor purchased $25 million of convertible senior secured promissory notes (the "Notes") from Evofem. Most notably, in the Fourth Amendment, the Investor withdraws and waives the March 2023 Event of Default and allows for the Company to repurchase the Notes for no more than $25 million.

Key Points:

Most notably, in the Fourth Amendment, the Investor withdraws and waives the March 2023 Event of Default and allows for the Company to repurchase the Notes for no more than $25 million.
"We deeply appreciate that the Investor has worked with us to amend the 2020 S.P.A. in a way that respects their initial investment while dramatically strengthening our financial position, facilitating execution of our growth strategy, and positioning Evofem for future success," said Saundra Pelletier, CEO of Evofem Biosciences.
Evofem will pay the Investor $1 million by October 1, 2023, which will be applied towards the eventual Note repurchase price.
Furthermore, for five years or until the date of repurchase, whichever is earlier, Evofem will pay the Investor a low single-digit percentage of its global net product sales.